IQV · News · 20260809N

Revenue Performance and Mix

IQVIA HOLDINGS INC. · 2026-08-09 · Importance 75 · Surprise 60

IQVIA raised its full-year 2026 revenue guidance to US$17.28–US$17.48 billion. The revised outlook was reported alongside the Medera cardiac gene-therapy collaboration, which could support activity in advanced cardiovascular research services. The report also identified pricing pressure and margin strain in CRO contracts as factors investors should monitor, but provided no quantified change to revenue or margins.